Keros Therapeutics, Inc. (KROS) Gross margin
Keros Therapeutics, Inc. (KROS) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to KROSSource: SEC XBRL filings · For reference only · Not investment advice
More KROS financial trends
KROS RevenueKROS Net incomeKROS Net marginKROS Gross profitKROS Operating incomeKROS Operating marginKROS Operating cash flowKROS Free cash flowKROS Capital expendituresKROS Return on equityKROS Stock buybacksKROS Dividends paidKROS Total assetsKROS Total liabilitiesKROS Shareholders’ equityKROS overview →